Clinical-Pathologic Correlation and Guideline Concordance in Resectable Non-Small Cell Lung Cancer

ConclusionsClinical staging modalities are reasonably accurate. However, less than half of Stage IIA-IIIA NSCLC patients receive guideline-concordant therapy which is associated with inferior survival. Identifying factors contributing to these differences is crucial to improve outcomes.Graphical abstract
Source: The Annals of Thoracic Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research